Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs

Psychedelic experiences share many features with those described by mystics and religious practitioners

by Eric W. Dolan
September 5, 2020
in Psychedelic Drugs
(Photo credit: agsandrew)

(Photo credit: agsandrew)

Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

Scientists in Finland are taking a closer look the relationship between psychedelic substances and mystical experiences. In new research published in Journal of Psychoactive Drugs, researchers show that a Finnish version of a common assessment of subjective psychedelic effects can accurately capture individuals’ experiences.

“Studies with both clinical populations and healthy volunteers, as well as population-based research, suggest that some people experience positive changes in well-being and relationships after using psychedelics,” said study author Samuli Kangaslampi, a postdoctoral researcher at Tampere University.

“Undergoing mystical-type experiences under their influence may be one possible mechanism that could lead to such changes. However, research on psychedelic-induced mystical-type experiences has been limited to a few distinct cultural environments, and there was little to no previous research from Nordic contexts on psychedelics in general. This may be relevant in a complex phenomenon such as mystical-type experiences and their meaning and relevance.”

In a study of 288 psychedelic users who were fluent in Finnish, the researchers found that a Finnish translation of the 30-item revised Mystical Experience Questionnaire was a valid and reliable measure of mystical experiences. The revised Mystical Experience Questionnaire, also known as the MEQ30, was initially developed in English to assess the occurrence and character of discrete mystical experiences, such as the feeling that one has transcended time and space.

Kangaslampi and his colleagues found that those who scored high on the MEQ30 were more likely to also describe their psychedelic experience as mystical, spiritual, or religious, as well as more personally significant. “Correlations with the experience being fun, sad, or difficult were also significant, but weaker,” the researchers said.

“Even when taken for the first time, psychedelics may occasion powerful subjective experiences that share many features with those described by mystics, dedicated meditators, and religious practitioners. Researchers studying psychedelics are developing ways of assessing such experiences as well as their meaning and possible effects. Some research is beginning to demonstrate that undergoing a mystical-type experience may be linked to improved relationships with self, others, and the natural environment later on,” Kangaslampi told PsyPost.

Creating a scientifically-validated translation of the MEQ30 provides new opportunities for researchers to investigate the effects of psychedelic drugs.

“The goal of this study was mainly to validate a measure of mystical experiences and begin to elucidate whether psychedelic-induced mystical-type experiences, their features, and their relevance differ in different cultural contexts. As such, the sample this research is based is not intended to be representative of all people who take psychedelics for the first time, in Finland or in general. Moreover, participants were reporting on first times that in many cases took place years earlier,” Kangaslampi explained.

“As for the role and relevance of mystical-type experiences more generally, we face two major questions. First, the possible unique contribution of mystical-type experiences in promoting positive changes after psychedelic use when other putative psychological mechanisms of change are taken into account remains to be established.”

“Second, while powerful and profound experiences occur in many users of psychedelics, there is still debate about whether their relevant features are most appropriately described as mystical-type experiences, peak experiences, or emotional breakthroughs,” Kangaslampi said.

The study, “Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland“, was authored by Samuli Kangaslampi, Aino Hausen, and Tarina Rauteenmaa.

TweetSendScanShareSendPin5ShareShareShareShareShare

RELATED

Some dark personality traits may help buffer against depression, new psychology research suggests
Mental Health

Psilocybin-assisted therapy linked to reduced depression in people with bipolar disorder, small study finds

June 17, 2025

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder. The treatment appeared well-tolerated, with no signs of mania or psychosis, offering cautious optimism for future bipolar depression research.

Read moreDetails
Psilocybin from “magic” mushrooms weakens the brain’s response to angry faces
Addiction

Single-dose psilocybin therapy shows promise for reducing alcohol consumption

June 15, 2025

Early results from a pilot study indicate that psilocybin-assisted therapy could be linked to lower alcohol consumption and improved psychological outcomes, though larger controlled trials are needed to determine whether the psilocybin itself is responsible for these changes.

Read moreDetails
Psilocybin appears to have a uniquely powerful relationship with nature relatedness
Neuroimaging

Psilocybin induces large-scale brain network reorganization, offering insights into the psychedelic state

June 14, 2025

A new study using high-resolution EEG reveals that psilocybin dramatically alters brain connectivity in rats. The psychedelic induced dose-dependent changes in network organization, disrupting normal patterns of neural communication and suggesting rodents may be viable models for studying altered consciousness.

Read moreDetails
Brain chemistry imbalance revealed in violent offenders with antisocial personality disorder
LSD

Flipping two atoms in LSD turned it into a powerful treatment for damaged brain circuits

June 13, 2025

A new study introduces JRT, a modified version of LSD that promotes brain cell growth without triggering hallucinations. Researchers say this non-hallucinogenic compound could offer safer treatment options for schizophrenia and related brain disorders where psychedelics are typically contraindicated.

Read moreDetails
Brain connectivity maps shed light on the synergistic effects of meditation and psilocybin
Psychedelic Drugs

Psychedelic experiences can both cause and resolve spiritual struggles, study suggests

June 12, 2025

A new study has found that people frequently described both relief from spiritual tension and the emergence of new spiritual struggles following psychedelic use.

Read moreDetails
Meta-analysis highlights potential of psilocybin therapy for treatment-resistant depression
Depression

Psilocybin therapy shows similar benefits for patients with and without recent antidepressant use

June 11, 2025

A new study finds that individuals with treatment-resistant depression experienced similar improvements from psilocybin-assisted psychotherapy whether or not they had recently discontinued antidepressant medications.

Read moreDetails
Ayahuasca entity encounters linked to lasting religious belief changes, especially in men
Ayahuasca

Ayahuasca entity encounters linked to lasting religious belief changes, especially in men

June 8, 2025

A new study suggests that vivid encounters with perceived entities during ayahuasca experiences are associated with reduced atheism and increased spirituality, particularly among men. Before the experience, men were less religious—but gender differences disappeared afterward.

Read moreDetails
Ayahuasca retreat participants report greater gratitude and nature appreciation after the experience, study finds
Psychedelic Drugs

Psychedelics may buffer against PTSD, finds new study of survivors of Nova music festival massacre

June 7, 2025

A new study of Nova festival massacre survivors suggests that taking classic psychedelics before the attack was linked to lower anxiety and trauma symptoms weeks later, offering rare insights into how psychedelics may influence trauma memory formation in real-world settings.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Scientists demonstrate superior cognitive benefits of outdoor vs indoor physical activity

Racial insecurity helped shield Trump from Republican backlash after Capitol riot, study suggests

Frequent pornography use linked to altered brain connectivity and impaired cognitive performance

Childhood trauma linked to changes in brain structure and connectivity, study finds

Psilocybin-assisted therapy linked to reduced depression in people with bipolar disorder, small study finds

COVID-19 coverage linked to rise in anti-Asian sentiment, especially among Trump supporters

Some dark personality traits may help buffer against depression, new psychology research suggests

Dementia risk begins in childhood, not old age, scientists warn

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy